Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
AFT Leaves X Over AI-Generated Images of Minors 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
LOS ANGELES, April 04, 2017 -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against USANA Health Sciences, Inc. (“USANA” or the “Company”) (NYSE:USNA) concerning possible violations of federal securities laws between March 14, 2014 and February 7, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the April 14, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, USANA made materially false and/or misleading statements and/or failed to disclose that: the Company’s BabyCare Ltd. subsidiary engaged in improper reimbursement practices in China; that these practices constituted violations of the Foreign Corrupt Practices Act; that the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; that the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and that as a result of the above, USANA’s public statements were materially false and misleading at all relevant times.
On February 7, 2017, USANA announced that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act...and certain conduct and policies at BabyCare, including BabyCare’s expense reimbursement policies.” When this information was released to the public, shares of USANA fell in value, causing investors harm.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
